Generic Ranitidine/Zantac Recalled Due to Carcinogenic Contamination

According to a spokesperson from Novartis, the distribution of Zantac by Novartis and ranitidine (the over-the-counter generic drug of this brand) has been halted by worldwide markets after a Connecticut-based pharmacy reported to the FDA that they found extremely high levels of N-Nitrosodimethylamine (NDMA), a probable cancer-causing ingredient, in all tested batches of generic ranitidineContinue reading “Generic Ranitidine/Zantac Recalled Due to Carcinogenic Contamination”